▶ 調査レポート

世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のトランスフォーミング増殖因子ベータ 2市場規模・現状・予測(2021年-2027年) / Global Transforming Growth Factor Beta 2 Market Size, Status and Forecast 2021-2027 / QFJ1-6050資料のイメージです。• レポートコード:QFJ1-6050
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、87ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医薬品
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、トランスフォーミング増殖因子ベータ 2の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(XOMA-089、トラベダーセン、ISTH-0047、その他)、用途別市場規模(多形性膠芽腫、開放隅角緑内障、肝線維症、黒色腫、乳がん、その他)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・トランスフォーミング増殖因子ベータ 2の市場動向
・企業の競争状況、市場シェア
・トランスフォーミング増殖因子ベータ 2の種類別市場規模と予測2016-2027(XOMA-089、トラベダーセン、ISTH-0047、その他)
・トランスフォーミング増殖因子ベータ 2の用途別市場規模と予測2016-2027(多形性膠芽腫、開放隅角緑内障、肝線維症、黒色腫、乳がん、その他)
・トランスフォーミング増殖因子ベータ 2の北米市場規模2016-2027(アメリカ、カナダ)
・トランスフォーミング増殖因子ベータ 2の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・トランスフォーミング増殖因子ベータ 2のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・トランスフォーミング増殖因子ベータ 2の中南米市場規模2016-2027(メキシコ、ブラジル)
・トランスフォーミング増殖因子ベータ 2の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Autotelic Inc、Genzyme Corp、Isarna Therapeutics GmbH、Novartis AG)
・結論

Market Analysis and Insights: Global Transforming Growth Factor Beta 2 Market
The global Transforming Growth Factor Beta 2 market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Transforming Growth Factor Beta 2 market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Transforming Growth Factor Beta 2 market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Transforming Growth Factor Beta 2 market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Transforming Growth Factor Beta 2 market.

Global Transforming Growth Factor Beta 2 Scope and Market Size
Transforming Growth Factor Beta 2 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transforming Growth Factor Beta 2 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
XOMA-089
Trabedersen
ISTH-0047
Others

Segment by Application
Glioblastoma Multiforme
Open-Angle Glaucoma
Liver Fibrosis
Melanoma
Breast Cancer
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Autotelic Inc
Genzyme Corp
Isarna Therapeutics GmbH
Novartis AG

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transforming Growth Factor Beta 2 Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 XOMA-089
1.2.3 Trabedersen
1.2.4 ISTH-0047
1.2.5 Others
1.3 Market by Application
1.3.1 Global Transforming Growth Factor Beta 2 Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Glioblastoma Multiforme
1.3.3 Open-Angle Glaucoma
1.3.4 Liver Fibrosis
1.3.5 Melanoma
1.3.6 Breast Cancer
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Transforming Growth Factor Beta 2 Market Perspective (2016-2027)
2.2 Transforming Growth Factor Beta 2 Growth Trends by Regions
2.2.1 Transforming Growth Factor Beta 2 Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Transforming Growth Factor Beta 2 Historic Market Share by Regions (2016-2021)
2.2.3 Transforming Growth Factor Beta 2 Forecasted Market Size by Regions (2022-2027)
2.3 Transforming Growth Factor Beta 2 Industry Dynamic
2.3.1 Transforming Growth Factor Beta 2 Market Trends
2.3.2 Transforming Growth Factor Beta 2 Market Drivers
2.3.3 Transforming Growth Factor Beta 2 Market Challenges
2.3.4 Transforming Growth Factor Beta 2 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Transforming Growth Factor Beta 2 Players by Revenue
3.1.1 Global Top Transforming Growth Factor Beta 2 Players by Revenue (2016-2021)
3.1.2 Global Transforming Growth Factor Beta 2 Revenue Market Share by Players (2016-2021)
3.2 Global Transforming Growth Factor Beta 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Transforming Growth Factor Beta 2 Revenue
3.4 Global Transforming Growth Factor Beta 2 Market Concentration Ratio
3.4.1 Global Transforming Growth Factor Beta 2 Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transforming Growth Factor Beta 2 Revenue in 2020
3.5 Transforming Growth Factor Beta 2 Key Players Head office and Area Served
3.6 Key Players Transforming Growth Factor Beta 2 Product Solution and Service
3.7 Date of Enter into Transforming Growth Factor Beta 2 Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Transforming Growth Factor Beta 2 Breakdown Data by Type
4.1 Global Transforming Growth Factor Beta 2 Historic Market Size by Type (2016-2021)
4.2 Global Transforming Growth Factor Beta 2 Forecasted Market Size by Type (2022-2027)

5 Transforming Growth Factor Beta 2 Breakdown Data by Application
5.1 Global Transforming Growth Factor Beta 2 Historic Market Size by Application (2016-2021)
5.2 Global Transforming Growth Factor Beta 2 Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Transforming Growth Factor Beta 2 Market Size (2016-2027)
6.2 North America Transforming Growth Factor Beta 2 Market Size by Type
6.2.1 North America Transforming Growth Factor Beta 2 Market Size by Type (2016-2021)
6.2.2 North America Transforming Growth Factor Beta 2 Market Size by Type (2022-2027)
6.2.3 North America Transforming Growth Factor Beta 2 Market Size by Type (2016-2027)
6.3 North America Transforming Growth Factor Beta 2 Market Size by Application
6.3.1 North America Transforming Growth Factor Beta 2 Market Size by Application (2016-2021)
6.3.2 North America Transforming Growth Factor Beta 2 Market Size by Application (2022-2027)
6.3.3 North America Transforming Growth Factor Beta 2 Market Size by Application (2016-2027)
6.4 North America Transforming Growth Factor Beta 2 Market Size by Country
6.4.1 North America Transforming Growth Factor Beta 2 Market Size by Country (2016-2021)
6.4.2 North America Transforming Growth Factor Beta 2 Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Transforming Growth Factor Beta 2 Market Size (2016-2027)
7.2 Europe Transforming Growth Factor Beta 2 Market Size by Type
7.2.1 Europe Transforming Growth Factor Beta 2 Market Size by Type (2016-2021)
7.2.2 Europe Transforming Growth Factor Beta 2 Market Size by Type (2022-2027)
7.2.3 Europe Transforming Growth Factor Beta 2 Market Size by Type (2016-2027)
7.3 Europe Transforming Growth Factor Beta 2 Market Size by Application
7.3.1 Europe Transforming Growth Factor Beta 2 Market Size by Application (2016-2021)
7.3.2 Europe Transforming Growth Factor Beta 2 Market Size by Application (2022-2027)
7.3.3 Europe Transforming Growth Factor Beta 2 Market Size by Application (2016-2027)
7.4 Europe Transforming Growth Factor Beta 2 Market Size by Country
7.4.1 Europe Transforming Growth Factor Beta 2 Market Size by Country (2016-2021)
7.4.2 Europe Transforming Growth Factor Beta 2 Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Transforming Growth Factor Beta 2 Market Size (2016-2027)
8.2 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type
8.2.1 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type (2016-2027)
8.3 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application
8.3.1 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application (2016-2027)
8.4 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Region
8.4.1 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Transforming Growth Factor Beta 2 Market Size (2016-2027)
9.2 Latin America Transforming Growth Factor Beta 2 Market Size by Type
9.2.1 Latin America Transforming Growth Factor Beta 2 Market Size by Type (2016-2021)
9.2.2 Latin America Transforming Growth Factor Beta 2 Market Size by Type (2022-2027)
9.2.3 Latin America Transforming Growth Factor Beta 2 Market Size by Type (2016-2027)
9.3 Latin America Transforming Growth Factor Beta 2 Market Size by Application
9.3.1 Latin America Transforming Growth Factor Beta 2 Market Size by Application (2016-2021)
9.3.2 Latin America Transforming Growth Factor Beta 2 Market Size by Application (2022-2027)
9.3.3 Latin America Transforming Growth Factor Beta 2 Market Size by Application (2016-2027)
9.4 Latin America Transforming Growth Factor Beta 2 Market Size by Country
9.4.1 Latin America Transforming Growth Factor Beta 2 Market Size by Country (2016-2021)
9.4.2 Latin America Transforming Growth Factor Beta 2 Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Transforming Growth Factor Beta 2 Market Size (2016-2027)
10.2 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type
10.2.1 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type (2016-2027)
10.3 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application
10.3.1 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application (2016-2027)
10.4 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Country
10.4.1 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Autotelic Inc
11.1.1 Autotelic Inc Company Details
11.1.2 Autotelic Inc Business Overview
11.1.3 Autotelic Inc Transforming Growth Factor Beta 2 Introduction
11.1.4 Autotelic Inc Revenue in Transforming Growth Factor Beta 2 Business (2016-2021)
11.1.5 Autotelic Inc Recent Development
11.2 Genzyme Corp
11.2.1 Genzyme Corp Company Details
11.2.2 Genzyme Corp Business Overview
11.2.3 Genzyme Corp Transforming Growth Factor Beta 2 Introduction
11.2.4 Genzyme Corp Revenue in Transforming Growth Factor Beta 2 Business (2016-2021)
11.2.5 Genzyme Corp Recent Development
11.3 Isarna Therapeutics GmbH
11.3.1 Isarna Therapeutics GmbH Company Details
11.3.2 Isarna Therapeutics GmbH Business Overview
11.3.3 Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Introduction
11.3.4 Isarna Therapeutics GmbH Revenue in Transforming Growth Factor Beta 2 Business (2016-2021)
11.3.5 Isarna Therapeutics GmbH Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Transforming Growth Factor Beta 2 Introduction
11.4.4 Novartis AG Revenue in Transforming Growth Factor Beta 2 Business (2016-2021)
11.4.5 Novartis AG Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Transforming Growth Factor Beta 2 Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of XOMA-089
Table 3. Key Players of Trabedersen
Table 4. Key Players of ISTH-0047
Table 5. Key Players of Others
Table 6. Global Transforming Growth Factor Beta 2 Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Transforming Growth Factor Beta 2 Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Transforming Growth Factor Beta 2 Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Transforming Growth Factor Beta 2 Market Share by Regions (2016-2021)
Table 10. Global Transforming Growth Factor Beta 2 Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Transforming Growth Factor Beta 2 Market Share by Regions (2022-2027)
Table 12. Transforming Growth Factor Beta 2 Market Trends
Table 13. Transforming Growth Factor Beta 2 Market Drivers
Table 14. Transforming Growth Factor Beta 2 Market Challenges
Table 15. Transforming Growth Factor Beta 2 Market Restraints
Table 16. Global Transforming Growth Factor Beta 2 Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Transforming Growth Factor Beta 2 Market Share by Players (2016-2021)
Table 18. Global Top Transforming Growth Factor Beta 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transforming Growth Factor Beta 2 as of 2020)
Table 19. Ranking of Global Top Transforming Growth Factor Beta 2 Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Transforming Growth Factor Beta 2 Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Transforming Growth Factor Beta 2 Product Solution and Service
Table 23. Date of Enter into Transforming Growth Factor Beta 2 Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Transforming Growth Factor Beta 2 Revenue Market Share by Type (2016-2021)
Table 27. Global Transforming Growth Factor Beta 2 Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Transforming Growth Factor Beta 2 Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Transforming Growth Factor Beta 2 Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Transforming Growth Factor Beta 2 Revenue Market Share by Application (2016-2021)
Table 31. Global Transforming Growth Factor Beta 2 Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Transforming Growth Factor Beta 2 Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Transforming Growth Factor Beta 2 Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Transforming Growth Factor Beta 2 Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Transforming Growth Factor Beta 2 Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Transforming Growth Factor Beta 2 Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Transforming Growth Factor Beta 2 Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Transforming Growth Factor Beta 2 Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Transforming Growth Factor Beta 2 Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Transforming Growth Factor Beta 2 Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Transforming Growth Factor Beta 2 Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Transforming Growth Factor Beta 2 Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Transforming Growth Factor Beta 2 Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Transforming Growth Factor Beta 2 Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Transforming Growth Factor Beta 2 Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Transforming Growth Factor Beta 2 Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Transforming Growth Factor Beta 2 Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Transforming Growth Factor Beta 2 Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Transforming Growth Factor Beta 2 Market Size by Country (2022-2027) & (US$ Million)
Table 63. Autotelic Inc Company Details
Table 64. Autotelic Inc Business Overview
Table 65. Autotelic Inc Transforming Growth Factor Beta 2 Product
Table 66. Autotelic Inc Revenue in Transforming Growth Factor Beta 2 Business (2016-2021) & (US$ Million)
Table 67. Autotelic Inc Recent Development
Table 68. Genzyme Corp Company Details
Table 69. Genzyme Corp Business Overview
Table 70. Genzyme Corp Transforming Growth Factor Beta 2 Product
Table 71. Genzyme Corp Revenue in Transforming Growth Factor Beta 2 Business (2016-2021) & (US$ Million)
Table 72. Genzyme Corp Recent Development
Table 73. Isarna Therapeutics GmbH Company Details
Table 74. Isarna Therapeutics GmbH Business Overview
Table 75. Isarna Therapeutics GmbH Transforming Growth Factor Beta 2 Product
Table 76. Isarna Therapeutics GmbH Revenue in Transforming Growth Factor Beta 2 Business (2016-2021) & (US$ Million)
Table 77. Isarna Therapeutics GmbH Recent Development
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Transforming Growth Factor Beta 2 Product
Table 81. Novartis AG Revenue in Transforming Growth Factor Beta 2 Business (2016-2021) & (US$ Million)
Table 82. Novartis AG Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Transforming Growth Factor Beta 2 Market Share by Type: 2020 VS 2027
Figure 2. XOMA-089 Features
Figure 3. Trabedersen Features
Figure 4. ISTH-0047 Features
Figure 5. Others Features
Figure 6. Global Transforming Growth Factor Beta 2 Market Share by Application: 2020 VS 2027
Figure 7. Glioblastoma Multiforme Case Studies
Figure 8. Open-Angle Glaucoma Case Studies
Figure 9. Liver Fibrosis Case Studies
Figure 10. Melanoma Case Studies
Figure 11. Breast Cancer Case Studies
Figure 12. Others Case Studies
Figure 13. Transforming Growth Factor Beta 2 Report Years Considered
Figure 14. Global Transforming Growth Factor Beta 2 Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Transforming Growth Factor Beta 2 Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Transforming Growth Factor Beta 2 Market Share by Regions: 2020 VS 2027
Figure 17. Global Transforming Growth Factor Beta 2 Market Share by Regions (2022-2027)
Figure 18. Global Transforming Growth Factor Beta 2 Market Share by Players in 2020
Figure 19. Global Top Transforming Growth Factor Beta 2 Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transforming Growth Factor Beta 2 as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Transforming Growth Factor Beta 2 Revenue in 2020
Figure 21. Global Transforming Growth Factor Beta 2 Revenue Market Share by Type (2016-2021)
Figure 22. Global Transforming Growth Factor Beta 2 Revenue Market Share by Type (2022-2027)
Figure 23. North America Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Transforming Growth Factor Beta 2 Market Share by Type (2016-2027)
Figure 25. North America Transforming Growth Factor Beta 2 Market Share by Application (2016-2027)
Figure 26. North America Transforming Growth Factor Beta 2 Market Share by Country (2016-2027)
Figure 27. United States Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Transforming Growth Factor Beta 2 Market Share by Type (2016-2027)
Figure 31. Europe Transforming Growth Factor Beta 2 Market Share by Application (2016-2027)
Figure 32. Europe Transforming Growth Factor Beta 2 Market Share by Country (2016-2027)
Figure 33. Germany Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Transforming Growth Factor Beta 2 Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Transforming Growth Factor Beta 2 Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Transforming Growth Factor Beta 2 Market Share by Region (2016-2027)
Figure 43. China Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Transforming Growth Factor Beta 2 Market Share by Type (2016-2027)
Figure 51. Latin America Transforming Growth Factor Beta 2 Market Share by Application (2016-2027)
Figure 52. Latin America Transforming Growth Factor Beta 2 Market Share by Country (2016-2027)
Figure 53. Mexico Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Transforming Growth Factor Beta 2 Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Transforming Growth Factor Beta 2 Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Transforming Growth Factor Beta 2 Market Share by Country (2016-2027)
Figure 59. Turkey Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Transforming Growth Factor Beta 2 Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Autotelic Inc Revenue Growth Rate in Transforming Growth Factor Beta 2 Business (2016-2021)
Figure 63. Genzyme Corp Revenue Growth Rate in Transforming Growth Factor Beta 2 Business (2016-2021)
Figure 64. Isarna Therapeutics GmbH Revenue Growth Rate in Transforming Growth Factor Beta 2 Business (2016-2021)
Figure 65. Novartis AG Revenue Growth Rate in Transforming Growth Factor Beta 2 Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed